Dicerna Pharmaceuticals, Inc.
METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF ALPHA-1 ANTITRYPSIN BY DOUBLE-STRANDED RNA
Last updated:
Abstract:
This invention relates to compounds, compositions, and methods useful for reducing .alpha.-1 antitrypsin target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Status:
Application
Type:
Utility
Filling date:
1 Jul 2020
Issue date:
17 Jun 2021